Print ISSN:-2581-5555

Online ISSN:-2456-9542

CODEN : IIJCDU

Article History

Received : 10-04-2021

Accepted : 13-04-2021



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 1035

PDF Downloaded: 592


Medicinal plants effective against Alzheimer’s disease: An update


Full Text PDF Share on Facebook Share on Twitter


Review Article

Author Details : Sofia Khanam*, C. Ananda Vayaravel

Volume : 6, Issue : 1, Year : 2021

Article Page : 22-27

https://doi.org/10.18231/j.ijcaap.2021.004



Suggest article by email

Get Permission

Abstract

Alzheimer’s disease (AD) is a memory-related neurodegenerative disease that affects individuals as they grow older. AD is highly devastating; beginning with memory problems and progressing to total dependency and failure to perform daily activities. Several trials have been conducted in order to discover therapeutic approaches for AD, however, the proper cure is still unavailable. Late initiation of AD drugs is argued to decrease their efficacy. While AD has no cure, symptomatic therapy can help with memory and
other dementia-related issues. Due to the complexities of the underlying pathologies, the lack of diseasemodifying medications necessitates the production of newer medicinal agents and various target-based techniques. Many herbs and herbal formulations have been used for memory and cognitive enhancement in the past, and many of them have been researched thoroughly in the last few years for therapeutic efficacy in AD. The effectiveness of most herbs and plants has been confirmed in clinical trials and has been chemically tested. This study will concentrate on recent scientific results on the effectiveness of different plants in the
management of AD based on their memory boosting, neuroprotective, antioxidant, and anti-inflammatory effects.

Keywords: Alzheimer’s disease, Neurodegenerative disease, Medicinal plants, Therapeutic efficacy.



How to cite : Khanam S , Vayaravel C A, Medicinal plants effective against Alzheimer’s disease: An update. IP Int J Compr Adv Pharmacol 2021;6(1):22-27


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.